Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Haschke

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|June 23, 2010
Pharmacokinetics and pharmacodynamics of nasally delivered midazolamManuel Haschke, Katja Suter, Sarah Hofmann, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 19, 2006
Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantationVolker Schmitz, Jost Klawitter, Jamie Bendrick-Peart, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2019
Prognostic impact of polypharmacy and drug interactions in patients with advanced cancerAlexander Hoemme, Holger Barth, Manuel Haschke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 19, 2019
Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal filmKlara Kiene, Noriyuki Hayasi, Jürgen Burhenne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2014
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovirJohn P Sabo, Jens Kort, Charles Ballow, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Basic & Clinical Pharmacology & Toxicology|April 27, 2017
Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib TreatmentZinnia P Parra-Guillen, Peter B Berger, Manuel Haschke, et al.
Frontiers in Genetics|September 25, 2020
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced AgranulocytosisAnca Liliana Cismaru, Livia Grimm, Deborah Rudin, et al.
Cells|April 3, 2021
Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive PatientsAnnina S Vischer, Gabriela M Kuster, Raphael Twerenbold, et al.
Nephron. Experimental Nephrology|March 19, 2009
Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantationVolker Schmitz, Jost Klawitter, Jamie Bendrick-Peart, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|June 23, 2010
Pharmacokinetics and pharmacodynamics of nasally delivered midazolamManuel Haschke, Katja Suter, Sarah Hofmann, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 19, 2006
Impact of organ preservation using HTK for graft flush and subsequent storage in UW in rat kidney transplantationVolker Schmitz, Jost Klawitter, Jamie Bendrick-Peart, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2019
Prognostic impact of polypharmacy and drug interactions in patients with advanced cancerAlexander Hoemme, Holger Barth, Manuel Haschke, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 19, 2019
Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal filmKlara Kiene, Noriyuki Hayasi, Jürgen Burhenne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2014
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovirJohn P Sabo, Jens Kort, Charles Ballow, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover StudySamuel E Christen, Laura Hermann, Elias Bekka, et al.
Basic & Clinical Pharmacology & Toxicology|April 27, 2017
Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib TreatmentZinnia P Parra-Guillen, Peter B Berger, Manuel Haschke, et al.
Frontiers in Genetics|September 25, 2020
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced AgranulocytosisAnca Liliana Cismaru, Livia Grimm, Deborah Rudin, et al.
Cells|April 3, 2021
Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive PatientsAnnina S Vischer, Gabriela M Kuster, Raphael Twerenbold, et al.
Nephron. Experimental Nephrology|March 19, 2009
Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantationVolker Schmitz, Jost Klawitter, Jamie Bendrick-Peart, et al.
Pageof 10